Programme
Confirmed Speakers
​
-
ITOC8 Lifetime Achievement Award
UÄŸur Åžahin and Özlem Türeci
BioNTech SE, Mainz, Germany
"Translating the success of the mRNA vaccine to cancer"
In alphabectical order
​
-
Niroshana Anandasabapathy, Weill Cornell New York, NY, USA
-
Mads Hald Andersen, National Center for Cancer Immune Therapy, Copenhagen, Denmark
-
Gregory L. Beatty, University of Pennsylvania, Philadelphia, PA, USA
-
Marcus Bosenberg, Yale School of Medicine, New Haven, CT, USA
-
Philippe Bousso, Department of Immunology, Institut Pasteur and INSERM, Paris, France
-
Tullia C. Bruno, UPMC Hillman Cancer Center, Pittsburgh, PA, USA
-
Dirk Busch, TUM, Munich, Germany
-
Toos Daemen, University Medical Center Groningen, The Netherlands
-
May Daher, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
-
Tanja de Gruijl, Cancer Center Amsterdam, The Netherlands
-
Bernard A. Fox, Providence Portland Medical Center, Portland, OR, USA
-
Saar Gill, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
-
Brent Hanks, Duke University, Durham, NC, USA
-
Maija Hollmen, University of Turku, Turku, Finland
-
David S. Hong, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
-
Samuel Huber, University of Hamburg, Faculty of Medicine, Hamburg, Germany
-
Sebastian Kobold, Ludwig-Maximilians-Universität, Munich, Germany
-
Nicolaus Kröger, University Hospital Hamburg-Eppendorf, Hamburg, Germany
-
X. Shirley Liu, Dana-Farber Cancer Institute and Harvard University, Boston, MA, USA
-
Jason J. Luke, University of Pittsburgh Medical Center, Pittsburgh PA, USA
-
Fathia Mami-Chouaib, Institut de Cancérologie Gustave Roussy, Villejuif, France
-
Cornelis Melief, ISA Pharmaceuticals, Leiden, The Netherlands
-
Meriem Messaoudene, Centre Hospitalier de l'Université de Montréal, Canada
-
Patrick A. Ott, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, USA
-
Chong-Xian Pan, Harvard Medical School, Boston, MA, USA
-
Stanley R Riddell, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA
-
Marco Ruella, University of Pennsylvania, Philadelphia, PA, USA
-
Sabina Signoretti, Harvard Medical School, Department of Pathology, Boston, MA, USA
-
Philipp Staber, Medical University of Vienna, Austria
-
Febe van Maldegem, The Francis Crick Institute, London, United Kingdom
-
Michael von Bergwelt, LMU, CCC, DKTK, Munich, Germany
-
Dietmar Zehn, Animal Physiology and Immunology, Technical University of Munich, Germany
​
The website is continuously updated as feedback from invited speakers is received.
ITOC8 has been granted 11 European CME credits
Session Topics
-
​Emerging Concepts / New Agents
-
Tumor microenvironment and microbiome in Immunotherapy
-
Vaccine Therapy
-
Pro & Contra Session
-
Precision Medicine Meets Immunotherapy (Immuno-Monitoring)
-
“Lost in Translation”?
-
Lifetime Achievement Award
-
Cell Therapy in Solid Tumors
-
Cell Therapy in Haematologic Diseases
-
Combination Therapy
-
Young Researchers Session
-
Best Poster Awards